| Regeneron Pharmaceuticals, Inc. |
Level II |
30 | 135 |
$145,108 |
| Icahn School of Medicine at Mount Sinai |
Level II |
17 | 17 |
$88,617 |
| New York Genome Center, Inc. |
Level II |
7 | 7 |
$94,491 |
| Schrodinger, Inc. |
Level II |
7 | 7 |
$154,100 |
| Brookhaven National Laboratory |
Level I |
5 | 5 |
$82,638 |
| NYU Grossman School of Medicine |
Level I |
5 | 5 |
$85,701 |
| NYU Grossman School of Medicine |
Level II |
5 | 5 |
$91,114 |
| Tempus AI |
Level I |
5 | 5 |
$147,700 |
| Regeneron Pharmaceuticals, Inc. |
Level III |
4 | 4 |
$158,723 |
| Schrodinger, Inc. |
Level IV |
4 | 4 |
$198,400 |
| Brookhaven National Laboratory |
Level II |
3 | 3 |
$85,137 |
| Brookhaven National Laboratory |
Level III |
3 | 3 |
$146,744 |
| Cold Spring Harbor Laboratory |
Level I |
3 | 3 |
$78,000 |
| Columbia University |
Level II |
3 | 3 |
$82,870 |
| Howard Hughes Medical Institute |
Level II |
3 | 3 |
$87,965 |
| Pharmerit International, LP |
Level II |
3 | 3 |
$96,054 |
| Regeneron Genetics Center, LLC |
Level II |
3 | 21 |
$155,004 |
| The Research Foundation for Mental Hygiene, Inc. |
Level I |
3 | 3 |
$75,245 |
| Tempus AI |
Level IV |
3 | 3 |
$175,200 |
| Albert Einstein College of Medicine |
Level II |
2 | 2 |
$87,029 |
| Azenta, Inc. |
Level I |
2 | 2 |
$90,858 |
| Bristol-Myers Squibb Company |
Level III |
2 | 2 |
$141,316 |
| Bristol-Myers Squibb Company |
Level IV |
2 | 2 |
$149,955 |
| CD Biosciences Inc. |
Level IV |
2 | 2 |
$138,466 |
| Celltrion Branchburg, LLC |
Level III |
2 | 2 |
$132,480 |
| Cold Spring Harbor Laboratory |
Level II |
2 | 2 |
$86,434 |
| ImClone Systems LLC |
Level III |
2 | 2 |
$128,000 |
| Memorial Sloan Kettering Cancer Center |
Level I |
2 | 2 |
$93,500 |
| Memorial Sloan Kettering Cancer Center |
Level IV |
2 | 2 |
$304,000 |
| NILO Therapeutics, Inc. |
Level I |
2 | 2 |
$86,600 |
| ORDAOS INC |
Level III |
2 | 2 |
$125,000 |
| Prime Education LLC |
Level II |
2 | 2 |
$120,000 |
| Regeneron Genetics Center, LLC |
Level III |
2 | 2 |
$168,448 |
| Regeneron Genetics Center, LLC |
Level IV |
2 | 2 |
$174,191 |
| The Rockefeller University |
Level II |
2 | 2 |
$87,550 |
| Tempus AI |
Level III |
2 | 2 |
$182,650 |
| Waypoint Bio, Inc |
Level IV |
2 | 2 |
$138,466 |
| Amgen Inc. |
Level IV |
1 | 1 |
$150,000 |
| Arc Research Institute |
Level I |
1 | 1 |
$80,000 |
| BlueRock Therapeutics, LP |
Level III |
1 | 1 |
$117,250 |
| The Broad Institute, Inc. |
Level II |
1 | 1 |
$101,793 |
| City University of New York School of Medicine |
Level I |
1 | 1 |
$79,997 |
| Cogent Scientific, LLC |
Level II |
1 | 1 |
$97,500 |
| Columbia University |
Level I |
1 | 1 |
$72,280 |
| CZ Biohub New York, LLC |
Level III |
1 | 1 |
$138,000 |
| EUROIMMUN US, Inc. |
Level III |
1 | 1 |
$121,471 |
| GenScript USA Inc. |
Level I |
1 | 1 |
$75,000 |
| GenScript USA Inc. |
Level III |
1 | 1 |
$128,000 |
| Guardant Health, Inc. |
Level IV |
1 | 1 |
$138,466 |
| Howard Hughes Medical Institute |
Level III |
1 | 1 |
$107,100 |
| Howard Hughes Medical Institute |
Level IV |
1 | 1 |
$214,352 |
| Icahn School of Medicine at Mount Sinai |
Level I |
1 | 1 |
$72,280 |
| Icahn School of Medicine at Mount Sinai |
Level III |
1 | 1 |
$117,520 |
| Illumina Software, Inc. |
Level III |
1 | 1 |
$155,600 |
| Immunai Inc. |
Level III |
1 | 1 |
$125,000 |
| InstaDeep LLC |
Level IV |
1 | 1 |
$185,000 |
| Janssen Research & Development, LLC |
Level III |
1 | 1 |
$170,200 |
| Janssen Research & Development, LLC |
Level IV |
1 | 1 |
$138,466 |
| Jefferies LLC |
Level II |
1 | 1 |
$200,000 |
| Jefferies LLC |
Level IV |
1 | 1 |
$200,000 |
| Lantheus Medical Imaging, Inc. |
Level III |
1 | 1 |
$117,250 |
| Manhattan Genomics Inc. |
Level II |
1 | 1 |
$130,000 |
| Memorial Sloan Kettering Cancer Center |
Level II |
1 | 1 |
$115,000 |
| Memorial Sloan Kettering Cancer Center |
Level III |
1 | 1 |
$100,000 |
| Merck Sharp & Dohme LLC |
Level II |
1 | 1 |
$117,000 |
| Merck Sharp & Dohme LLC |
Level III |
1 | 1 |
$126,464 |
| Natera, Inc. |
Level IV |
1 | 1 |
$167,877 |
| New York Genome Center, Inc. |
Level III |
1 | 1 |
$108,000 |
| NEW YORK STRUCTURAL BIOLOGY CENTER |
Level I |
1 | 1 |
$92,260 |
| New York University |
Level I |
1 | 1 |
$72,280 |
| New York University |
Level II |
1 | 1 |
$85,000 |
| NILO Therapeutics, Inc. |
Level III |
1 | 1 |
$118,000 |
| NORTHWELL HEALTH |
Level I |
1 | 1 |
$82,808 |
| NOVARTIS PHARMACEUTICALS CORPORATION |
Level II |
1 | 1 |
$96,054 |
| NOVARTIS PHARMACEUTICALS CORPORATION |
Level IV |
1 | 1 |
$138,466 |
| OverT Bio, Inc. |
Level I |
1 | 1 |
$96,054 |
| Paradigm Health, Inc. |
Level II |
1 | 1 |
$185,000 |
| Pharmaceutical Research Associates, Inc. |
Level I |
1 | 1 |
$94,023 |
| Piping Rock Health Products, Inc. |
Level I |
1 | 1 |
$94,098 |
| Point72 Asset Management, L.P. |
Level IV |
1 | 1 |
$150,000 |
| Protheragen Inc. |
Level III |
1 | 1 |
$117,250 |
| Research Foundation for the State University of New York |
Level III |
1 | 1 |
$95,000 |
| Research Foundation of CUNY |
Level I |
1 | 1 |
$72,280 |
| The Rockefeller University |
Level III |
1 | 1 |
$132,031 |
| RTW INVESTMENTS, LP |
Level IV |
1 | 1 |
$140,000 |
| Schrodinger, Inc. |
Level I |
1 | 1 |
$135,000 |
| SPRING FERTILITY MANAGEMNET LLC |
Level III |
1 | 1 |
$260,000 |
| Sumitomo Pharma America, Inc. |
Level III |
1 | 1 |
$131,006 |
| Tandem AI, US LLC |
Level III |
1 | 1 |
$120,000 |
| Tempus AI |
Level II |
1 | 1 |
$150,000 |
| The University of Chicago |
Level II |
1 | 1 |
$87,569 |
| Weill Cornell Medical College |
Level I |
1 | 1 |
$80,000 |
| Weill Cornell Medical College |
Level II |
1 | 1 |
$82,867 |
| Weill Cornell Medical College |
Level III |
1 | 6 |
$93,475 |
| Weill Cornell Medical College |
Level IV |
1 | 1 |
$106,090 |
| Wilson Sonsini Goodrich & Rosati, PC |
Level IV |
1 | 1 |
$185,000 |
| WuXi Biologics USA, LLC |
Level IV |
1 | 1 |
$229,320 |
| XenoBiotic Laboratories, Inc., a div. of WuXi |
Level I |
1 | 1 |
$85,000 |
| ZIFO TECHNOLOGIES, INC |
Level I |
1 | 1 |
$84,753 |
| Admera Health LLC |
Level I |
1 | 1 |
$81,795 |